Pulmonx (LUNG) Invested Capital (2019 - 2025)
Historic Invested Capital for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $97.2 million.
- Pulmonx's Invested Capital fell 2592.08% to $97.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.2 million, marking a year-over-year decrease of 2592.08%. This contributed to the annual value of $122.7 million for FY2024, which is 2091.54% down from last year.
- Pulmonx's Invested Capital amounted to $97.2 million in Q3 2025, which was down 2592.08% from $106.2 million recorded in Q2 2025.
- Pulmonx's Invested Capital's 5-year high stood at $233.5 million during Q1 2021, with a 5-year trough of $97.2 million in Q3 2025.
- In the last 5 years, Pulmonx's Invested Capital had a median value of $170.9 million in 2022 and averaged $166.3 million.
- In the last 5 years, Pulmonx's Invested Capital surged by 22032.5% in 2021 and then crashed by 2592.08% in 2025.
- Quarter analysis of 5 years shows Pulmonx's Invested Capital stood at $210.1 million in 2021, then decreased by 18.67% to $170.9 million in 2022, then dropped by 9.2% to $155.2 million in 2023, then dropped by 20.92% to $122.7 million in 2024, then decreased by 20.82% to $97.2 million in 2025.
- Its last three reported values are $97.2 million in Q3 2025, $106.2 million for Q2 2025, and $114.9 million during Q1 2025.